Real-world assessment of Fluorecare SARS-CoV-2 Spike Protein Test Kit

Real-world assessment of Fluorecare SARS-CoV-2 Spike Protein Test Kit

Since commercial SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2) antigen rapid detection tests (Ag-RDTs) display broad diagnostic efficiency, this study aimed to evaluate the clinical performance of Fluorecare SARS-CoV-2 Spike Protein Test Kit in a real-life scenario.

Guardado en:
Detalles Bibliográficos
Autores principales: Salvagno Gian Luca, Gianfilippi Gianluca, Pighi Laura, De Nitto Simone, Henry Brandon M., Lippi Giuseppe
Formato: article
Lenguaje:EN
ES
Publicado: De Gruyter 2021
Materias:
covid-19
diagnosis
immunoassay
laboratory medicine
sars-cov-2
Medical technology
R855-855.5
Acceso en línea:https://doaj.org/article/14ecfcde489d42ceb1e699de7d1452a4
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Internet

https://doaj.org/article/14ecfcde489d42ceb1e699de7d1452a4

Ejemplares similares